Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study

MLA

Gabriella Fabbrocini, et al. “Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.” Journal of Investigational Allergy and Clinical Immunology, vol. 32, Apr. 2022, pp. 124–32. EBSCOhost, https://doi.org/10.18176/jiaci.0641.

APA

Gabriella Fabbrocini, L Bonzano, Silvia Ferrucci, S Ribero, Simona Tavecchio, Giovanni Pellacani, Steven Paul Nisticò, C Detoraki, Franco Rongioletti, Cataldo Patruno, Paolo Romita, Eustachio Nettis, Viviana Piras, Michela Ortoncelli, M Carbonara, Giulia Calabrese, Danilo Di Bona, E. Di Leo, Luigi Macchia, … Maddalena Napolitano. (2022). Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study. Journal of Investigational Allergy and Clinical Immunology, 32, 124–132. https://doi.org/10.18176/jiaci.0641

Chicago

Gabriella Fabbrocini, L Bonzano, Silvia Ferrucci, S Ribero, Simona Tavecchio, Giovanni Pellacani, Steven Paul Nisticò, et al. 2022. “Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.” Journal of Investigational Allergy and Clinical Immunology 32 (April): 124–32. doi:10.18176/jiaci.0641.